Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
HONG KONG, Oct 20, 2022 – (ACN Newswire via SEAPRWire.com) – VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as “VectorBuilder”), a top gene delivery enterprise, recently announced the completion […]